<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Definium Therapeutics Inc (DFTX)</title>
    <description>Latest news, press releases, and SEC filings for Definium Therapeutics Inc (DFTX)</description>
    <link>https://caymanjournal.com/stock/DFTX</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 20:27:45 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/DFTX/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>8-K — Definium Therapeutics, Inc.</title>
      <description># 📋 What This Document Is 🚀

This filing is an 8-K, which is a highly important filing used by companies to quickly announce major, unscheduled corporate events. This specific filing is related to an Investor and Analyst Day, meaning it serves as a deep dive into Definium Therapeutics&apos; (DFTX) prog</description>
      <link>https://caymanjournal.com/stock/DFTX/sec-filing/0001193125-26-170509</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/DFTX/sec-filing/0001193125-26-170509</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>